Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00089869 · ClinicalTrials.gov registry record · Phase 1
A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00089869: Completed Phase 1 study, sponsored by Eli Lilly and Company.
NCT00089869 is a Phase 1 study that has completed, run by Eli Lilly and Company. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00089869, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
Study of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, Zyprexa
Interventions
- DRUG placebo
- DRUG olanzapine
- DRUG atomoxetine
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00089869 record still lists
NCT00089869 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00089869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00089869 about?
NCT00089869 is a clinical study titled "A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia". Study of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, Zyprexa
What is the current status of trial NCT00089869?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00089869?
The interventions under investigation include: placebo (DRUG), olanzapine (DRUG), atomoxetine (DRUG).
Who is sponsoring clinical trial NCT00089869?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.